Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.

Source:http://linkedlifedata.com/resource/pubmed/id/12225798

Download in:

View as

General Info

PMID
12225798